Aadi Bioscience Future Growth
Future criteria checks 2/6
Aadi Bioscience is forecast to grow earnings and revenue by 45.7% and 45.5% per annum respectively while EPS is expected to grow by 46% per annum.
Key information
45.7%
Earnings growth rate
46.0%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | 45.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Mar 2024 |
Recent future growth updates
Recent updates
Improved Revenues Required Before Aadi Bioscience, Inc. (NASDAQ:AADI) Stock's 28% Jump Looks Justified
Mar 07
Here's Why We're Watching Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation
Feb 12Why Investors Shouldn't Be Surprised By Aadi Bioscience, Inc.'s (NASDAQ:AADI) 48% Share Price Plunge
Dec 16Analysts Have Lowered Expectations For Aadi Bioscience, Inc. (NASDAQ:AADI) After Its Latest Results
Nov 10Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Oct 03Here's Why We're Not Too Worried About Aadi Bioscience's (NASDAQ:AADI) Cash Burn Situation
Jun 28Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Mar 04Aadi Bioscience highlights combination of KRAS inhibitors and nab-sirolimus for tumors
Oct 12A Look At The Fair Value Of Aadi Bioscience, Inc. (NASDAQ:AADI)
Sep 28Aadi Bioscience: Taking mTOR Inhibition To The Next Level
Sep 21Is Aadi Bioscience (NASDAQ:AADI) In A Good Position To Deliver On Growth Plans?
Jul 06Aadi Bioscience to enter Russell 2000 and Russell 3000 indexes
Jun 23What You Need To Know About The Aadi Bioscience, Inc. (NASDAQ:AADI) Analyst Downgrade Today
Nov 27Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
Nov 25Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 91 | -41 | -64 | N/A | 3 |
| 12/31/2025 | 32 | -85 | -76 | N/A | 3 |
| 12/31/2024 | 28 | -69 | -72 | N/A | 3 |
| 12/31/2023 | 24 | -66 | -64 | -60 | N/A |
| 9/30/2023 | 23 | -63 | -65 | -61 | N/A |
| 6/30/2023 | 22 | -62 | -60 | -58 | N/A |
| 3/31/2023 | 19 | -62 | -53 | -52 | N/A |
| 12/31/2022 | 15 | -61 | -50 | -50 | N/A |
| 9/30/2022 | 11 | -63 | -51 | -51 | N/A |
| 6/30/2022 | 7 | -136 | -60 | -60 | N/A |
| 3/31/2022 | 3 | -119 | -52 | -52 | N/A |
| 12/31/2021 | 1 | -111 | -22 | -22 | N/A |
| 9/30/2021 | 14 | -87 | -13 | -13 | N/A |
| 6/30/2021 | 15 | -2 | 1 | 1 | N/A |
| 3/31/2021 | 15 | -6 | 2 | 2 | N/A |
| 12/31/2020 | 15 | -4 | -13 | -13 | N/A |
| 12/31/2019 | 1 | -13 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AADI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AADI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AADI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AADI's revenue (45.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: AADI's revenue (45.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AADI's Return on Equity is forecast to be high in 3 years time